These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27181719)

  • 1. [Cell therapy for Parkinson's disease].
    Morizane A; Takahashi J
    Nihon Yakurigaku Zasshi; 2016 May; 147(5):264-8. PubMed ID: 27181719
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
    Beaulieu-Boire I; Fasano A
    Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
    Morizane A
    Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural transplantation for the treatment of Parkinson's disease.
    Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
    Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular replacement therapy for Parkinson's disease--where we are today?
    Redmond DE
    Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review.
    Staudt MD; Di Sebastiano AR; Xu H; Jog M; Schmid S; Foster P; Hebb MO
    Gerontology; 2016; 62(3):371-80. PubMed ID: 26330171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesias after transplantation in Parkinson's disease.
    Piccini P
    Lancet Neurol; 2002 Dec; 1(8):472. PubMed ID: 12849327
    [No Abstract]   [Full Text] [Related]  

  • 8. Fetal cell implantation to treat Parkinson's disease: questions for the future.
    Kondziolka D
    Neurosurgery; 2001 Sep; 49(3):582-5. PubMed ID: 11523667
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell transplantation: a future therapy for Parkinson's disease?
    Lindvall O
    Neurologia; 1994 Mar; 9(3):101-7. PubMed ID: 8204256
    [No Abstract]   [Full Text] [Related]  

  • 10. Parkinson's transplant therapy faces setback.
    Check E
    Nature; 2003 Aug; 424(6952):987. PubMed ID: 12944933
    [No Abstract]   [Full Text] [Related]  

  • 11. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.
    Maries E; Kordower JH; Chu Y; Collier TJ; Sortwell CE; Olaru E; Shannon K; Steece-Collier K
    Neurobiol Dis; 2006 Jan; 21(1):165-80. PubMed ID: 16095907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
    Barker RA; Kuan WL
    Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are dyskinesias a problem after neural transplantation for Parkinson's disease?
    Bradbury J
    Lancet; 2002 Jun; 359(9322):2007. PubMed ID: 12076564
    [No Abstract]   [Full Text] [Related]  

  • 14. The future of cell therapies in the treatment of Parkinson's disease.
    Laguna Goya R; Kuan WL; Barker RA
    Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [iPS cell therapy for Parkinson's disease].
    Takahashi J
    Rinsho Ketsueki; 2016 Aug; 57(8):1080-6. PubMed ID: 27599427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease.
    Arias-Carrión O; Salama M
    Med Hypotheses; 2011 Aug; 77(2):312-3. PubMed ID: 21669496
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of Parkinson's disease. Symptomatic cell therapies: cells as biological minipumps.
    Zurn AD; Tseng J; Aebischer P
    Eur Neurol; 1996; 36(6):405-8. PubMed ID: 8954314
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of neurotrophin-5 on the growth and survival of nigral grafts in a rat model of Parkinson's disease.
    Haque NS; Hlavin ML; Fawcett J; Dunnett SB
    Gene Ther; 1994; 1 Suppl 1():S60. PubMed ID: 8542406
    [No Abstract]   [Full Text] [Related]  

  • 19. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 20. Fetal tissue implants: therapy for Parkinson's disease?. Interview by Kevin Tanzillo.
    Berg P; Montagnier L; Jagiello G
    Geriatrics; 1992 Jul; 47(7):70-1, 75-6. PubMed ID: 1618400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.